Patents by Inventor Shay EIZENBERGER

Shay EIZENBERGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDES AND USE OF SAME IN THE TREATMENT OF DISEASES, DISRODERS OR CONDITIONS ASSOCIATED WITH A MUTANT P53
    Publication number: 20220251159
    Abstract: An isolated peptide is provided. The peptide comprises an amino acid sequence arranged in a space and configuration that allow interaction of the peptide with the DNA Binding Domain (DBD) of p53 through at least one residue of the DBD by which pCAP 250 (SEQ ID NO: 1) binds the DBD, wherein the peptide at least partially reactivates a mutant p53 protein, with the proviso that the peptide is not SEQ ID NO: 59-382.
    Type: Application
    Filed: December 13, 2021
    Publication date: August 11, 2022
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO., LTD
    Inventors: Varda ROTTER, Moshe OREN, Perry TAL, Shay EIZENBERGER, Avi BEN-SHIMON
  • PEPTIDES AND USE OF SAME IN THE TREATMENT OF DISEASES, DISORDERS OR CONDITIONS ASSOCIATED WITH A MUTANT P53
    Publication number: 20190048053
    Abstract: An isolated peptide is provided. The peptide comprises an amino acid sequence arranged in a space and configuration that allow interaction of the peptide with the DNA Binding Domain (DBD) of p53 through at least one residue of the DBD by which pCAP 250 (SEQ ID NO: 1) binds the DBD, wherein the peptide at least partially reactivates a mutant p53 protein, with the proviso that the peptide is not SEQ ID NO: 59-382.
    Type: Application
    Filed: February 3, 2017
    Publication date: February 14, 2019
    Inventors: Varda ROTTER, Moshe OREN, Perry TAL, Shay EIZENBERGER, Avi BEN-SHIMON